I learned a tremendous amount and thought your speakers, moderators and panelists were very high quality. Thank you very much for putting together an informative session.
Leslie HeyisonDirector
Pfizer
- Why oncology market access models must evolve
The proliferation of stakeholders makes oncology market access increasingly complex—and successful models increasingly essential. Peter Mansell reports.
4:59am, 7th Sep 2010 - Comprehensive strategies for market access
Alan Crofts outlines the flexible market access strategies needed to address the needs of clinical and non-clinical decision makers.
4:51am, 7th Sep 2010 - Market access: Risk sharing and alternative pricing schemes
Shared-risk agreements can represent uncertain rewards for drug makers and payers. What you need to know before entering into one.
9:33am, 10th Aug 2010
This is the must-attend senior-level event for all executives in the pharmaceutical industry.
Featuring industry-led keynote presentations, case studies, panel debates and high-level networking, this is a crucial opportunity for any executive striving to make the most out of cutting-edge and alternative sales & marketing innovation best-practices:
- How to overcome Market Access hurdles? Learn to build an effective Market Access strategy and improve communication with payers
- Health reform survival guide: Equip yourself with the knowledge you need to successfully build and guide your team
- Build your brand to deliver consistence and value which is reinforced by effective marketing communications
- Identify the key factors that influence your drug's pricing and reimbursement level
Meet 200+ of your peers, stakeholders and business rivals at this agenda-setting event
Market Access is the current buzz word throughout the Pharma Industry. Whether you are involved in R&D, Pricing & Reimbursement, HEOR, Strategic Planning, Payer relations or Marketing, it affects you.
After six months of in-depth research with some of the industry's leading personalities the need of a meeting on Market Access emerged, where you will get the chance to talk to your colleagues and experts in the field to exchange strategy ideas and methodology secrets.
The conference will take place in Philadelphia PA on June 2-3 at the Crown Plaza Downtown. More than 100 delegates and 20 speakers will join us in order to create a solid communication and discussion platform around some of the most important issues.
Our speakers have been set the challenging task to present their views, but most importantly to answer your questions, so get them in early.
At eyeforpharma events, you set the agenda - guaranteed!
It's not what we want to talk about at the Market Access Summit - it's all about what you want to discuss. Which means you won't waste a single second at sessions that bear no relevance to your professional concerns. We've spent six months interviewing more than 100 pharma executives, drilling down with them into the issues that matter most.
The result?
A tailor-made agenda that reflects the prime day-by-day challenges you're up against in seven business-critical areas:
-
Market Access strategic overview
Define, Understand, Implement -
Pricing and Reimbursement
Achieve the best result -
Payer relations
Identify your payer's needs -
REMS
The acronym that will change your life -
Health Economics & Outcomes Research
Use HEOR to your competitive advantage -
Internal Organizational Structure
Set up the ideal team
As this is an event where your say plays a major role, the agenda will remain flexible and will be adjusted to your needs.
Get in touch now if you want to get involved or suggest a speaker who needs to be there! For the full program and details download the brochure here.
Speakers Confirmed Include
